Status:
COMPLETED
Cervical Cancer Screening in Cameroon
Lead Sponsor:
Albert Einstein College of Medicine
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Cancer
HIV/AIDS
Eligibility:
FEMALE
25-56 years
Phase:
NA
Brief Summary
Human immunodeficiency virus-infected (HIV\[+\]) women have a several-fold increased risk of invasive cervical cancer (ICC) as well as increased risk of cervical pre-cancer. In low- and middle-income ...
Eligibility Criteria
Inclusion
- Women living in Limbe town and neighborhood
- Confirmed to be HIV\[+\] or HIV\[-\]
- Have never undergone cervical cancer screening, with no history of ICC
- Willing and able to competently understand and provide written, informed paper-based consent
- Women who are having a menstrual period will be deferred for 2 weeks from participating in the study
Exclusion
- Pregnant women
- Women with signs of abnormalities
- Non-menstrual bleeding suggestive of ICC
- Without a cervix because they have undergone hysterectomy
- Based on the judgment of the clinicians not sufficiently healthy to participate in a research study
Key Trial Info
Start Date :
April 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
873 Patients enrolled
Trial Details
Trial ID
NCT04401670
Start Date
April 25 2017
End Date
May 1 2020
Last Update
May 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Limbé Regional Hospital
Limbe, Cameroon